scholarly journals Organ-sparing excision of pediatric testicular teratoma

2021 ◽  
Author(s):  
IV Poddubnyi ◽  
KN Tolstov ◽  
EV Fedorova ◽  
VO Trunov ◽  
MM Khanov ◽  
...  

Pediatric testicular masses are rare pathologies. Many physicians, facing such masses for the first time, have trouble choosing the algorithm of assessment and surgical treatment tactics. Extent of surgery and surgical approach depend directly on preoperative assessment results. The clinical case of the incident testicular mass surgical treatment in a 15-year-old boy is reported. The patient underwent laboratory and instrumental examination, the results of which confirmed a benign lesion. Based on the data obtained, the organ-sparing surgical approach was selected. An assessment algorithm, treatment tactics for testicular mass based on the data obtained, advisability and safety of the organ-sparing treatment approach are reported.

2021 ◽  
Vol 55 (8) ◽  
Author(s):  
Tania Saskianti ◽  
Angela Faustina Kartono ◽  
Ayudia Rifki ◽  
Yufita Fitriani ◽  
Pradita Agung Kurnia

A common benign lesion in children’s oral cavity is mucocele on the lower lips that originates from the accumulation of mucous due to local trauma and a lip-biting habit. Lip-biting is often motivated by a psychological condition of anxiety. Mucoceles are painless but can be bothersome for patients when eating and speaking. Mucoceles can affect the general population but are more common among the young. The etiology of oral mucoceles may vary, and surgical treatment is best chosen for its convenience, child-friendliness, and high treatment success rate. Awareness education for children and parents is necessary to eliminate a lip-biting habit. If the pattern persists due to anxiety, it is essential to inquire more about the etiology and consult a professional psychologist.


GYNECOLOGY ◽  
2018 ◽  
Vol 20 (1) ◽  
pp. 102-108
Author(s):  
Yu E Dobrokhotova ◽  
S E Arakelov ◽  
S Zh Danelyan ◽  
E I Borovkova ◽  
A E Zykov ◽  
...  

Associated with pregnancy is breast cancer, which was first detected during pregnancy, during the first year after childbirth or at any time against lactation. Diagnosis of the disease in the first trimester is an indication for abortion. The detection of the disease after 20 weeks and the desire of the woman to maintain pregnancy is the basis for conducting a total mastectomy followed by polychemotherapy with doxorubicin with cyclophosphamide or with fluorouracil. Radiation therapy during pregnancy is not applied. The timing and method of delivery are determined individually and depend on the stage of the process and the period of pregnancy, when it was identified. A clinical case of a patient with edematous-infiltrative form of breast cancer of the IV stage, diagnosed for the first time in 22 weeks of pregnancy, is presented.


2019 ◽  
Vol 17 (6 (part 2)) ◽  
pp. 84-85
Author(s):  
M. V. Plotnikov ◽  
◽  
E. A. Gaysina ◽  
R. M. Nuretdinov ◽  
L. M. Muhametdinova ◽  
...  

2020 ◽  
pp. 97-99
Author(s):  
U. V. Kukhtenko ◽  
O. A. Kosivtsov ◽  
L. A. Ryaskov ◽  
E. I. Abramian

A clinical case of successful surgical treatment of a patient with a giant cervical retrosternal nontoxic goiter with severe cardiac pathology is presented. Thyroidectomy from cervical access without sternotomy was performed. At the follow-up examination 5 months after the operation, instrumental and clinical signs of disease relapse were not detected.


Endocrines ◽  
2021 ◽  
Vol 2 (3) ◽  
pp. 241-250
Author(s):  
Marta Araujo-Castro ◽  
Eider Pascual-Corrales ◽  
Héctor Pian ◽  
Ignacio Ruz-Caracuel ◽  
Alberto Acitores Cancela ◽  
...  

Purpose: to determine whether pre-surgical treatment using long-acting somatostatin analogues (SSAs) may improve surgical outcomes in acromegaly. Methods: retrospective study of 48 patients with acromegaly operated by endoscopic transsphenoidal approach and for first time. Surgical remission was evaluated based on the 2010 criteria. Results: most patients, 83.3% (n = 40), harbored macroadenomas and 31.3% (n = 15) invasive pituitary adenomas. In this case, 14 patients were treated with lanreotide LAR and 6 with octreotide LAR, median monthly doses of 97.5 [range 60–120] and 20 [range 20–30] mg, respectively, for at least 3 months preoperatively. Presurgical variables were comparable between pre-treated and untreated patients (p > 0.05). Surgical remission was more frequent in those pre-treated with monthly doses ≥90 mg of lanreotide or ≥30 mg of octreotide than in untreated or pre-treated with lower doses (OR = 4.64, p = 0.025). However, no differences were found between pre-treated and untreated patients when lower doses were included or between those treated for longer than 6 months compared to those untreated or pre-treated for shorter than 6 months. Similarly, no differences were found either in terms of surgical or endocrine complications (OR = 0.65, p = 0.570), independently of the doses and the duration of SSA treatment (p > 0.05). Conclusions: the dose of SSAs is a key factor during pre-surgical treatment, since the beneficial effects in surgical remission were observed with monthly doses equal or higher than 90 mg of lanreotide and 30 mg of octreotide, but not with lower doses.


2021 ◽  
Vol 9 ◽  
pp. 2050313X2110251
Author(s):  
Michelle Aaron ◽  
Yu Qing Huang ◽  
Danielle Bouffard ◽  
Jean-Pascal Costa ◽  
Benoît Côté

A 66-year-old woman presented to the hospital with cutaneous necrosis of her right ankle and foot. Her symptoms began immediately after an intra-articular injection of hyaluronic acid for ankle osteoarthritis, which was performed 6 days before. Histopathology showed an intra-vascular hyaluronic acid embolus. The initial treatment approach was conservative, but the patient’s clinical state degraded. She was thus treated with sub-cutaneous hyaluronidase, the enzyme that degrades hyaluronic acid, which yielded a moderate improvement even though it was administered 22 days after the initial hyaluronic acid injection. Although hyaluronic acid embolism and subsequent cutaneous necrosis are well-known complications of dermal fillers, there are few reported cases of embolism following intra-articular injection. To our knowledge, this is the first time hyaluronidase has been used in this setting.


Sign in / Sign up

Export Citation Format

Share Document